Phases

Phases built their patient recruitment automation directly for clinical trial sponsors and contract research organizations (CROs)—the organizations running trials who struggle with slow, expensive patient screening. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Their assumption was that these buyers faced genuine pain: traditional recruitment takes months and costs millions, making it an obvious target for AI automation. The company validated this targeting early through direct engagement with trial operators who immediately recognized the bottleneck. When Phases demonstrated their AI agent conducting eligibility assessments via voice interviews on actual medical records, sponsors saw concrete time savings. The early signal that they'd found the right audience came from CROs' willingness to pilot the technology—these organizations had budget authority and measurable recruitment timelines they wanted to compress. However, available sources don't detail whether Phases discovered a different customer segment than anticipated or encountered unexpected adoption barriers during outreach. The company's expansion vision toward automating entire trial back-offices suggests they may have learned additional pain points beyond recruitment, but specific evidence of audience pivots or market discovery challenges isn't documented in accessible materials.